Inventory consisted of the following (in thousands):

Accrued and other liabilities consisted of the following (in thousands):


	March 31, 2023		December 31, 2022
Clinical studies	$	13,883	$	14,816
Professional fees	8,262		6,115
Short-term lease liability	5,738		5,591
Deferred revenue	5,841		5,342
Deferred payments for intangible assets	2,641		2,062
Accrued royalty	2,087		4,633
Laboratory processing fees and materials	1,760		2,189
License and other collaboration fees	1,017		1,000
Contingent consideration	825		1,025
Accrued shipping expenses	459		489
Capital expenditures	—		1,316
Other accrued expenses	4,372		4,553
Total accrued and other liabilities	$	46,885	$	49,131